KCTV: Atrial Fibrillation and New Treatment
Atrial fibrillation, or a-fib, is the most common type of treated heart arrhythmia, and it is estimated that 12.1 million people in the United States will have a-fib in 2030. Untreated, a-fib significantly increases your risk of heart attack and stroke, yet many people with a-fib have never been diagnosed.
Dr. Sanjaya Gupta, electrophysiologist at Saint Luke's Mid America Heart Institute, talks with KCTV about risk factors and new treatment available at Saint Luke's Atrial Fibrillation Clinic.
Relevant News
News
Jennifer Clark Named Hedrick Medical Center Employee of Quarter–Third Quarter 2026
News
FOX 4: Kansas City Oncologist: New Cancer Drug Is ‘Just the Tip of the Iceberg’
News
FOX 4: Suicide Prevention Month: Raising Awareness to Children's Mental Health Needs
News
Health News You Can Use: Saint Luke's Complex Aorta Disease Program
News
Healthy Kansas City: Home By Dinner: The Rise in Same-Day Discharge For Joint Replacement Surgeries
News